Renaissance Capital logo

Tarsus Pharmaceuticals Priced, Nasdaq: TARS

Phase 3 biotech developing therapies for ophthalmic conditions.

Industry: Health Care

Latest Trade: $26.60 0.00 (0.0%)

First Day Return: +28.6%

Return from IPO: +66.3%

Industry: Health Care

We are a late clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address large market opportunities initially in ophthalmic conditions where there are limited treatment alternatives. Our lead product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis. Blepharitis is a condition characterized by inflammation of the eyelid margin, redness and ocular irritation, including a specific type of eyelash dandruff called collarettes in Demodex blepharitis. According to published studies, there are an estimated 20 million patients in the United States who suffer from blepharitis, with approximately 45%, or approximately nine million, of cases caused by Demodex infestation. To date, we have completed four Phase 2 trials for TP-03 in Demodex blepharitis, all of which met their primary, secondary and/or exploratory endpoints, as applicable, and during which TP-03 was well tolerated. We have commenced our Phase 2b/3 trial, Saturn-1, in September 2020, and intend to commence our Phase 3 trial, Saturn-2, in 2021, both with primary and secondary endpoints consistent with those of our Europa and Io Phase 2 trials.
more less
IPO News for Tarsus Pharmaceuticals
more
IPO Data
IPO File Date 09/25/2020
Offer Price $16.00
Price Range $15.00 - $17.00
Offer Shares (mm) 5.5
Deal Size ($mm) $88
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 10/15/2020
Offer Price $16.00
Price Range $15.00 - $17.00
Offer Shares (mm) 5.5
Deal Size ($mm) $88
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
more
Company Data
Headquarters Irvine, CA
Founded 2016
Employees 12
Website www.tarsusrx.com